Professor Des Richardson
|
Professor of Cancer Cell Biology/NHMRC Senior Principal Research Fellow
D06 - Blackburn Building |
|
On this page
Themes | Research interests | Grants | Keywords
Themes
Research interests
Professor Richardson’s major contributions to cancer research are focussed on understanding the role of iron in cancer cell proliferation and the development of novel anti-tumour agents known as iron chelators. Indeed, these studies have resulted in highly promising and potent anti-cancer drugs and are subject of a suite of active national patents.
Current national competitive grants*
2010
Pharmacological Targeting via AKT, PTEN, and TGF-beta Pathway Integration using Novel Therapeutics
Richardson D, Assinder S, Dong Q
NHMRC Project Grant ($611,875 over 3 years)
Alpha-2-macroglobulin and the transport and uptake of the hormone, hepcidin
Richardson D, Suryo Rahmanto Y, Kuchel P
NHMRC Project Grant ($514,500 over 3 years)
The Effect of Nitrogen Monoxide on Intracellular Iron Metabolism
Richardson D
ARC Discovery Project ($540,000 over 3 years)
2009
Toxicological and pre-clinical assessment of the anti-cancer compound Bp4eT
Richardson D, Lovejoy D, Mills J
NHMRC Development Grants ($195,000 over 3 years)
Pharmacology of Potential Anti-Tumour Agents: Iron Chelators of the BpT Class
Richardson D, Kalinowski D, Lovejoy D, Bernhardt P
NHMRC Project Grants ($563,500 over 3 years)
Research Fellowship
Richardson D
NHMRC Research Fellowship ($766,250 over 5 years)
The Role of Melanoma Tumour Antigen p97 (Melanotransferrin) in Melanoma Tumourenesis
Richardson D, Suryo Rahmanto Y
NHMRC Project Grants ($541,250 over 3 years)
Development of Novel Drugs for the Treatment of Breast Cancer
Jansson P, Richardson D, Lovejoy D, Kalinowski D
Australian Rotary Health Research Fund Research Support ($27,000 over 1 year)
2008
The role of iron in Friedreich's Ataxia and the Use of Iron Chelation Therapy
Richardson D
Muscular Dystrophy Association (USA) Research Support ($542,379 over 3 years)
Development of Iron Chelators for the Treatment of Friedreichs Ataxia and the Role of Frataxin in Mitochondrial Iron Metabolism
Richardson D, Davies M
NHMRC Project Grant ($528,250 over 3 years)
Lipocalin 2 in host defence of the central nervous system
Campbell I, King N, Richardson D
NHMRC Project Grant ($549,500 over 4 years)
2007
Chemical and Biochemical Characterisation of Novel Iron Chelators with Therapeutic Potential
Bernhardt P, Richardson D
ARC Shared Research Support ($371,582 over 3 years)
NHMRC - Research Fellowship
Richardson D
NHMRC Research Fellowships ($651,250 over 5 years)
Examination of the Molecular Pharmacology of Anthracyclines Induced via their Interaction with Iron
Richardson D, Lovejoy D, Bernhardt P
NHMRC Project Grant ($594,750 over 3 years)
The effect of nitrogen monoxide on intracellular iron metabolism
Richardson D
ARC Discovery Projects ($377,000 over 3 years)
2006
Potential anti-tumour agents: iron chelators of the pyridoxal isonicotinoyl hydrazone class
Richardson D
NHMRC Project Grant ($462,750 over 4 years)
* Grants administered through the University of Sydney